穿

Rajendra Tangallapally1, Chitra Subramanian2, Mi-Kyung Yun3

  • 1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS1000, Memphis, Tennessee 38105, United States.

PubMed
概括

研究人员优化了氨酸激酶 (PANK) 激活剂,以提高协酶A (CoA) 水平. 这导致了神经退行性疾病和代谢障碍的新疗法,其中一种化合物进入临床试验.